Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer develops ACAT inhibitors

March 5, 1997

First launch for troglitazone

March 4, 1997

Pramlintide delays gastric emptying in IDDM

March 4, 1997

Comparative efficacy and tolerance of s.c. and i.m. Puregon

March 4, 1997

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

March 3, 1997

Genzyme Transgenics produces protential diabetes Rx in mouse milk

Feb. 28, 1997

Preliminary clinical data reported for OP-1

Feb. 26, 1997

Lilly claims compounds for postmenopausal syndrome

Feb. 26, 1997

Hemosol's blood substitute advances to phase II

Feb. 25, 1997

Agents for infertility described by Novo Nordisk

Feb. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...